R&D costs for each new drug on the market are estimated to be $800 million. Traditional molecular screening, although high-throughput, does not provide information about the effects of test compounds ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...